Clinical Trial Update: Diagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations.

View source ↗

Summary

This clinical trial update reviews diagnosis and treatment strategies for patients with stage IIIB/IV non-small cell lung cancer, including those with and witho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Stage IIIB/IV, Non-Small Cell Lung Cancer | Status: COMPLETED